Return to HOME
— Main Menu —
Home
Services
- Clinical & Medical Consulting
- Business Development
- Pharmaceutical
- Regulatory Affairs
- Legal Consulting
Our Team
- Michael Epstein, MD, FACG, AGAF
News
Blog
Contact
Home
Services
Clinical & Medical Consulting
Business Development
Pharmaceutical
Regulatory Affairs
Legal Consulting
Our Team
Michael Epstein, MD, FACG, AGAF
News
Blog
Contact
News
Biosimilars: The Need, The Challenge, The Future: The FDA Perspective
May 20, 2015
Comments are off
This article summarizes the brief history of the biosimilars industry, the FDA's regulations and guidance for biosimilars development, and the issues and challenges facing developers and regulators in bringing biosimilars to market.
Continue Reading →
1
2
3
Key Services
Clinical & Medical Consulting
Business Development
Pharmaceutical
Regulatory Affairs
Legal Consulting
News & Announcements
Achieving successful bowel preparation with evening/morning split-dosing regimens of NER1006 versus trisulfate: post hoc analysis of a Phase 3 trial
Jul 25, 2017
Novel 1L Polyethylene Glycol (PEG)-Based Bowel Preparation NER1006 Achieves High Quality Bowel Cleansing with a Lower Volume than Standard 2L PEG + Ascorbate and Under 3L Total Fluid Volume Intake
Jul 25, 2017
Bowel preparation quality of NER1006 versus oral trisulfate solution as assessed by colonoscopists at site: a post hoc analysis from a randomized controlled trial
Jul 25, 2017